Dupilumab Highly Effective in Refractory Atopic Dermatitis: Study Jacinthlyn Sylvia5 Feb 2026 8:30 PM ISTA new study published in the journal of Pediatric Dermatology revealed that treatment with dupilumab achieved effective disease control in 87.8% of...
Large-scale genetic study sheds light on the background of allergic conjunctivitis Dr. Kamal Kant Kohli2 Feb 2026 10:00 PM ISTItchy, red and watery eyes are familiar symptoms for many people, especially during the spring and summer pollen season. Allergic conjunctivitis is a...
Nemolizumab Rapidly Improves Itch and Sleep in Atopic Dermatitis and Prurigo Nodularis: Study Jacinthlyn Sylvia2 Feb 2026 8:30 PM ISTA new study published in the Journal of the European Academy of Dermatology and Venerology showed that nemolizumab, an interleukin-31 pathway...
PROMIS Measures effective tools for Assessing Impact of Chronic Skin Diseases: JAMA Dr Riya Dave29 Jan 2026 9:00 PM ISTA recent study published in JAMA Dermatology has demonstrated that PROMIS measures are valid tools for evaluating the physical, emotional, and social...
Tralokinumab Shows Sustained Efficacy in Hand Atopic Dermatitis: Study Dr. Kamal Kant Kohli27 Jan 2026 9:45 PM ISTThe ADHAND trial has demonstrated that tralokinumab significantly improved skin clarity, itch, and pain in adults with moderate-to-severe hand atopic...
Amlitelimab Shows Promise in Moderate-to-Severe Atopic Dermatitis in Phase 3 trial Dr. Kamal Kant Kohli24 Jan 2026 8:00 AM ISTAmlitelimab, an OX40 ligand-targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, demonstrated clinical...
Real-World Evidence Supports Dupilumab in Pediatric and Adult head and neck atopic dermatitis Patients: Study Dr. Shravani Dali1 Jan 2026 8:00 PM ISTResearchers have found in a new real-world study that dupilumab was an effective and safe therapeutic option for head and neck atopic dermatitis,...
Ivarmacitinib Shows Rapid, Sustained Efficacy in Moderate-to-Severe Atopic Dermatitis: Study Jacinthlyn Sylvia29 Dec 2025 8:30 PM ISTA new study published in the journal of Inflammopharmacology showed that in individuals with moderate-to-severe atopic dermatitis, ivarmacitinib shows...
JnJ discontinues mid stage study of skin disease drug Ruchika Sharma27 Dec 2025 3:30 PM ISTSpring House: Johnson & Johnson has discontinued a mid-stage trial of its experimental drug for moderate to severe atopic dermatitis after the...
Medical Bulletin 27/December/2025 Anshika Mishra27 Dec 2025 3:00 PM ISTHere are the top medical news for today:Study Links Mediterranean Diet to Lower Multiple Sclerosis Risk Levels Eating your way to brain health might...
Chronic Skin Problems May Secretly Drive Addictions, Study Finds Anshika Mishra27 Dec 2025 8:30 AM ISTLiving with a chronic skin condition can be far more than skin deep-it can quietly affect a person's mental health, emotions, and daily habits. A...
Nemolizumab Shows Rapid Efficacy in Treatment-Resistant Chronic Pruritus: Study Dr. Shravani Dali26 Dec 2025 8:30 PM ISTResearchers have found in a new study that Nemolizumab demonstrated rapid and meaningful symptom relief in patients with treatment-resistant chronic...
